Lazari Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Lazari Capital Management, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $15.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$15.8M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 16,168 | $3.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 8,709 | $2.4M |
| PFEPFIZER INC | 65,405 | $1.8M |
| JNJJOHNSON & JOHNSON | 6,121 | $1.5M |
| LLYELI LILLY & Co | 1,122 | $1.0M |
| BMYBRISTOL MYERS SQUIBB CO | 16,471 | $999K |
| AMGNAMGEN INC | 2,196 | $773K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 13,144 | $725K |
| MESOMesoblast Limited | 46,121 | $709K |
| MRKMerck & Co., Inc. | 5,666 | $682K |
| MCKMcKesson Corporation | 482 | $417K |
| PMPhilip Morris International Inc | 2,509 | $415K |
| TEVATeva Pharmaceutical Industries Limited | 10,503 | $316K |
| GILDGILEAD SCIENCES, INC. | 1,892 | $264K |
| GERNGERON CORP | 112,424 | $168K |
| MBOTMicrobot Medical Inc. | 23,255 | $56K |
| LCTXLineage Cell Therapeutics, Inc. | 10,500 | $17K |
| HUMAHumacyte Inc. | 13,144 | $8K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.